Roche will buy GenMark Diagnostics, a U.S.-based maker of molecular diagnostic tests in a US$1.8 billion deal, the Swiss pharmaceuticals manufacturer said on Monday.
Roche said it will launch a tender offer to fully acquire GenMark at a price of US$24.05 per share in an all-cash transaction. The price represented a premium of 43per cent on GenMark's closing share price on Feb. 10, before media speculation about a deal, Roche said.California-based GenMark provides molecular diagnostic tests that are designed to detect multiple pathogens from a single patient sample.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: TODAYonline - 🏆 1. / 99 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »